Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach

Mohamed Abd El-Aziz 0001, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong. Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach. Appl. Soft Comput., 97(Part):105509, 2020. [doi]

@article{AzizMHX20,
  title = {Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach},
  author = {Mohamed Abd El-Aziz 0001 and Yasmine S. Moemen and Aboul Ella Hassanien and Shengwu Xiong},
  year = {2020},
  doi = {10.1016/j.asoc.2019.105509},
  url = {https://doi.org/10.1016/j.asoc.2019.105509},
  researchr = {https://researchr.org/publication/AzizMHX20},
  cites = {0},
  citedby = {0},
  journal = {Appl. Soft Comput.},
  volume = {97},
  number = {Part},
  pages = {105509},
}